Showing results (121-130 of 129) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Molecular Cancer Therapeutics|October 20, 2021
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide TherapyJanik Puttemans, Benoit Stijlemans, Marleen Keyaerts, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 19, 2019
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumorsEvangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 20, 2023
Phase I Study of [<sup>68</sup>Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)Odrade Gondry, Catarina Xavier, Laurens Raes, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Evaluation of Antiatherogenic Properties of Ezetimibe Using <sup>3</sup>H-Labeled Low-Density-Lipoprotein Cholesterol and <sup>99m</sup>Tc-cAbVCAM1-5 SPECT in ApoE<sup>-/-</sup> Mice Fed the Paigen DietLaurent S Dumas, François Briand, Romain Clerc, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2015
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast CarcinomaMarleen Keyaerts, Catarina Xavier, Johannes Heemskerk, et al.Scientific Reports|November 11, 2017
A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cellsAlexander Balhuizen, Sam Massa, Iris Mathijs, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer PatientsMatthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.Diabetologia|February 4, 2014
Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendinMaarten Brom, Wietske Woliner-van der Weg, Lieke Joosten, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 2024
Phase II Trial Assessing the Repeatability and Tumor Uptake of [<sup>68</sup>Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast CarcinomaOdrade Gondry, Vicky Caveliers, Catarina Xavier, et al.Pageof 13